Nicotine Dependence Center

The U.S. celebrates another Great American Smokeout on Thursday, Nov. 18. The Centers for Disease Control and Prevention says tobacco use remains the leading cause [...]

For more than 40 years, the American Cancer Society has hosted the Great American Smokeout on the third Thursday in November. It's an opportunity for [...]

Tobacco users have an increased risk of becoming very sick if they contract the virus that causes COVID-19. If you use tobacco and want to [...]

As resolutions go, quitting smoking could be the most important choice on a smoker's list.

Smokers are more likely to develop diseases like lung, throat and [...]

While the cigarette smoking rate in the U.S. has dropped significantly in the past 50 years, from 42% in 1965 to 14% in 2017, millions [...]

Smoking is the most preventable cause of death in the world. Yet smoking remains a public health problem in many countries. To combat nicotine dependence, [...]

Millions of people use electronic cigarettes, or vaping devices. While tobacco use remains the largest cause of preventable death and disability in the U.S., vaping [...]

The use of electronic-cigarettes, or vaping devices, has been linked to one death and an outbreak of related lung injuries.

"The Center for Diseases Control [...]

As a lifelong smoker, Sue Franken had resigned herself to the unhealthy habit. But that changed when Sue followed through on a promise she made to her sister.

An annual survey by the Minnesota Department of Health recently revealed that 1 in 5 high school students use e-cigarettes. The survey also showed youth [...]

https://www.youtube.com/watch?v=1Dg5bncTJsg ROCHESTER, Minn. — A study of more than 1,500 cigarette smokers who were not ready to quit smoking but were willing to cut back on cigarette consumption and combine their approach with varenicline (Chantix) increased their long-term success of quitting smoking. The multinational study is published in the February issue of the Journal of the American Medical Association. Jon Ebbert, M.D., associate director for research in the Mayo Clinic Nicotine Dependence Center, was lead author on the study that reported the effects of the prescription medication varenicline for increasing smoking abstinence rates among smokers who wanted to reduce the number of cigarettes they smoked before trying to quit completely. “This study is important because this opens the door to treatment for approximately 14 million smokers who have no intention of quitting in the next 30 days but are willing to reduce their smoking rate while working toward a quit attempt,” says Dr. Ebbert. “In the past, these smokers may have not received medication therapy, and we want them to know that different approaches are available.” Journalists: Sound bites with Dr. Ebbert are available in the downloads. MEDIA CONTACT: Bryan Anderson, Mayo Clinic Public Affairs, 507-284-5005 Email: newsbureau@mayo.edu